Subacromial Impingement
Conditions
Brief summary
The purpose of this study is to assess the effectiveness of high intensity laser therapy in the treatment of subacromial impingement syndrome.
Detailed description
Shoulder pain has a high prevalence in our society, several studies estimate an annual prevalence between 5% and 47%. It is one of the main causes of musculoskeletal pain, particularly in third place, after the low back pain and neck pain. Symptoms of pathologies of subacromial space impingement syndrome, where, regardless of origin, pain is the number one symptom for the patient, which emanates functional impairment and the impact on quality of life. Because of the need to implement research to assess the effectiveness of high intensity laser therapy with new studies mayor methodological quality of obtaining conclusive results, and based on the scientific evidence supporting the low-power laser therapy as a useful tool in addressing the shoulder tendon pathology, we consider very interesting the realization of this research project.
Interventions
DEVICEiLux Laser
Treatment during 15 sessions. It is divided in two phases: 1. 12W. 50 Hz 20% duty cycle. 50 J/cm² in painful zone. 2. 15 W. Burst (10 pulses-900 msec each train) 250 J/cm² in painful zone. Trough the iLux Laser (Mectronic Medicale, Italy) \+ Physical Therapy protocol.
DEVICESham ilux Laser
Sham treatment during 15 sessions trough the iLux Laser (Mectronic Medicale, Italy), It is applies the same time than experimental one but with 0 W + Physical Therapy protocol.
Sponsors
Castilla-La Mancha Health Service
Hospital General Nuestra Señora del Prado
University of Castilla-La Mancha
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patients between 18 and 75 years old with diagnosis of subacromial impingement syndrome or any of the pathologies that compose it (tendinosis-tendinitis supraspinatus and rest of the rotator cuff, subacromial bursitis and tendinitis of the long head of the biceps). * Visual Analogue Scale (VAS) less than or equal to 7. * Forward flexion at least of 100º
Exclusion criteria
* Calcific tendinitis * Complete rupture of the rotator cuff. * Adhesive capsulitis. * Clinical history of pathologies that without affecting the shoulder joint refer to painful shoulder symptoms (cervical root involvement, cervical surgery, cervical osteoarthritis and neurological pathologies) * Fibromyalgia * Be receiving physiotherapeutic treatment or have received it previously for this pathology one month before the start of treatment. * Patients with alterations of thermal sensitivity. * Derived from the absolute and relative contraindications of Laser Therapy: * Photosensitive patients * Neoplastic processes * Hyperthyroidism * Pregnancy * Patients with a history of epileptic seizures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quick-Dash Abbreviated | Baseline | Quick- Dash Abbreviated test |
| Shoulder Pain and Disability Index (SPADI) | Baseline | SPADI test |
| Constant-Murley Score | Baseline | Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| VAS | Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment | Visual analogue scale |
| Painful pressure threshold | Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment | The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton. |
| Painful pressure threshold after first session | First session - 15 minutes after laser or sham treatment. | The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Quality of life | Baseline | EQ-5D™ is a standardised instrument for use as a measure of health outcome. |
Countries
Spain
Outcome results
None listed